The risk or severity of adverse effects can be increased when Miltefosine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Sacubitril is combined with Amlodipine. The risk or severity of adverse effects can be increased when Isoflurane is combined with Amlodipine. The risk or severity of adverse effects can be increased when Salicylic acid is combined with Amlodipine. The risk or severity of adverse effects can be increased when Nikkomycin Z is combined with Amlodipine. The serum concentration of Nintedanib can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Sinefungin is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Cobicistat. The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium Gluceptate. The serum concentration of Amlodipine can be increased when it is combined with Mifepristone. The risk or severity of adverse effects can be increased when Minoxidil is combined with Amlodipine. The risk or severity of adverse effects can be increased when Radicicol is combined with Amlodipine. The risk or severity of adverse effects can be increased when Cabergoline is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Imatinib. Tamsulosin may increase the hypotensive activities of Amlodipine. The serum concentration of Rilpivirine can be increased when it is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Nitrendipine. Amlodipine may increase the hypotensive activities of Bimatoprost. Quinine may increase the hypotensive activities of Amlodipine. Tadalafil may increase the antihypertensive activities of Amlodipine. The metabolism of Amlodipine can be decreased when combined with Solithromycin. Procarbazine may increase the hypotensive activities of Amlodipine. Udenafil may increase the antihypertensive activities of Amlodipine. Thiopental may increase the hypotensive activities of Amlodipine. The serum concentration of Edoxaban can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Cilazapril. Amlodipine may increase the hypotensive activities of Trichlormethiazide. The serum concentration of Vincristine can be increased when it is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Saquinavir. The serum concentration of Amlodipine can be increased when it is combined with Stiripentol. The serum concentration of Tacrolimus can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Ropivacaine is combined with Amlodipine. Methylphenidate may decrease the antihypertensive activities of Amlodipine. The metabolism of Amlodipine can be decreased when combined with Isavuconazonium. The risk or severity of adverse effects can be increased when Amlodipine is combined with Carvedilol. The metabolism of Amlodipine can be decreased when combined with Nelfinavir. The metabolism of Amlodipine can be decreased when combined with Darunavir. The serum concentration of Silodosin can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Sotalol. The risk or severity of adverse effects can be increased when Tioconazole is combined with Amlodipine. Phenelzine may increase the hypotensive activities of Amlodipine. Iloprost may increase the hypotensive activities of Amlodipine. The metabolism of Amlodipine can be decreased when combined with Crizotinib. The metabolism of Amlodipine can be increased when combined with Rifapentine. The serum concentration of Everolimus can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Butenafine is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Candoxatril. The risk or severity of adverse effects can be increased when Myxothiazol is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Delavirdine. The metabolism of Amlodipine can be decreased when combined with Dronedarone. Amlodipine may increase the hypotensive activities of Mibefradil. Amlodipine may increase the hypotensive activities of Phenoxybenzamine. Amlodipine may increase the hypotensive activities of Nilvadipine. The risk or severity of adverse effects can be increased when Cerulenin is combined with Amlodipine. The serum concentration of Amlodipine can be decreased when it is combined with St. John's Wort. Amlodipine may increase the hypotensive activities of Ambrisentan. Urapidil may increase the hypotensive activities of Amlodipine. Amlodipine may increase the hypotensive activities of Spirapril. The risk or severity of adverse effects can be increased when Thymol is combined with Amlodipine. The metabolism of Amlodipine can be increased when combined with Rifampicin. Amlodipine may increase the hypotensive activities of Omapatrilat. The risk or severity of adverse effects can be increased when Torasemide is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Niguldipine. The risk or severity of adverse effects can be increased when Haloprogin is combined with Amlodipine. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Amlodipine. Amlodipine may increase the hypotensive activities of Risperidone. Ketanserin may increase the hypotensive activities of Amlodipine. The metabolism of Amlodipine can be decreased when combined with Cyclosporine. Hexobarbital may increase the hypotensive activities of Amlodipine. Amlodipine may increase the hypotensive activities of Enalaprilat. Amlodipine may increase the hypotensive activities of Nitroprusside. The risk or severity of adverse effects can be increased when Amlodipine is combined with Apraclonidine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Prazosin. Amlodipine may increase the hypotensive activities of Xylometazoline. The metabolism of Amlodipine can be increased when combined with Lumacaftor. The serum concentration of Amlodipine can be increased when it is combined with Fosaprepitant. Methylene blue may increase the hypotensive activities of Amlodipine. The serum concentration of Fluvastatin can be increased when it is combined with Amlodipine. Thiamylal may increase the hypotensive activities of Amlodipine. The serum concentration of Amlodipine can be increased when it is combined with Aprepitant. Isocarboxazid may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Streptokinase is combined with Amlodipine. The risk or severity of adverse effects can be increased when Clozapine is combined with Amlodipine. Bucindolol may increase the hypotensive activities of Amlodipine. The serum concentration of Amlodipine can be increased when it is combined with Osimertinib. Barbexaclone may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Methazolamide. The risk or severity of adverse effects can be increased when Fimasartan is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Amlodipine. The risk or severity of adverse effects can be increased when Ergonovine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Micafungin is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Itraconazole. Amlodipine may increase the hypotensive activities of Phentolamine. The risk or severity of adverse effects can be increased when Pergolide is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Lisinopril. The risk or severity of adverse effects can be increased when Morphine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Isoxsuprine. The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Indapamide. The risk or severity of adverse effects can be increased when Flucytosine is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Ticlopidine. The risk or severity of adverse effects can be increased when Hexetidine is combined with Amlodipine. The serum concentration of Ranolazine can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Bretylium. Harmaline may increase the hypotensive activities of Amlodipine. Benmoxin may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Etacrynic acid. The metabolism of Amlodipine can be decreased when combined with Sulfisoxazole. The risk or severity of adverse effects can be increased when Natamycin is combined with Amlodipine. The risk or severity of adverse effects can be increased when Tolnaftate is combined with Amlodipine. Nicorandil may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Clevidipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Canagliflozin. The risk or severity of adverse effects can be increased when Amlodipine is combined with Diclofenamide. The risk or severity of adverse effects can be increased when Amlodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Amlodipine. The risk or severity of adverse effects can be increased when 2-HYDROXY-1,4-NAPHTHOQUINONE is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Zofenopril. Amlodipine may increase the hypotensive activities of Cafedrine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Empagliflozin. The serum concentration of Phenytoin can be increased when it is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Obinutuzumab. The serum concentration of Pravastatin can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Nisoldipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Methyldopa. The metabolism of Amlodipine can be increased when combined with Nevirapine. The therapeutic efficacy of Amlodipine can be decreased when used in combination with Casein. Guanadrel may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Carteolol. The risk or severity of adverse effects can be increased when Paclitaxel is combined with Amlodipine.